Unconventional Financial Incentives for Smoking Cessation
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03608852|
Recruitment Status : Not yet recruiting
First Posted : August 1, 2018
Last Update Posted : August 1, 2018
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||36 participants|
|Official Title:||Bad is Stronger Than Good: Unconventional Financial Incentives for Smoking Cessation|
|Estimated Study Start Date :||August 1, 2018|
|Estimated Primary Completion Date :||January 1, 2019|
|Estimated Study Completion Date :||August 1, 2019|
This group will have $50 placed in a 'bank account' for every clinic visit where their tests reveal abstinence from smoking. As a modified commitment contract, the Banked-Money Group can only withdraw the accrued money at the end of the trial if they complete the trial by quitting smoking for the entire 6 months.
This group will directly receive $50 for every clinic visit where their tests reveal abstinence from smoking.
- Smoking cessation rate [ Time Frame: 1 year ]The primary outcome for this study is to compare smoking cessation rates between smokers who received one of two financial incentive strategies in addition to standard of care NRT and counseling.
- Household income [ Time Frame: 1 year ]We will determine whether household income affect quit rates.
- Smoking habits [ Time Frame: 1 year ]We will determine whether smoking habits affect quit rates.
- Nicotine dependence [ Time Frame: 1 year ]We will determine whether nicotine dependence affect quit rates.
- Nicotine withdrawal symptoms [ Time Frame: 1 year ]We will determine whether nicotine withdrawal symptoms affect quit rates.
- Anxiety / Depression [ Time Frame: 1 year ]We will determine whether anxiety and / or depression affect quit rates.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03608852
|Contact: Isabel A Vital, MD||305-575-7000 ext email@example.com|
|Contact: Gisel Urdaneta, MD||305-575-7000 ext firstname.lastname@example.org|